Tai Ling Biotech Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 341.811 million compared to TWD 330.286 million a year ago. Operating income was TWD 10.218 million compared to operating loss of TWD 19.102 million a year ago. Net income was TWD 12.203 million compared to net loss of TWD 35.145 million a year ago. Basic earnings per share was TWD 0.34 compared to basic loss per share of TWD 0.98 a year ago.